Associated Papers
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting.
Bear AS et al.
Nature Communications, 2021
34272369 (PubMed )
Supplement: 41467_2021_24562_MOESM1_ESM.pdf
SensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations.
Riva A et al.
Plos One, 2017
Select a paper to view details